NIA SBIR Phase II
Funds small businesses advancing aging biology and Alzheimer's disease technologies through full development execution.
The National Institute on Aging (NIA) SBIR Phase II program funds full R&D execution by U.S. small businesses that have completed a qualifying Phase I project on the same technology or innovation. NIA manages approximately $150 million per year in combined SBIR and STTR grants, making it the largest federal funder of early-stage aging-related R&D. Phase II awards are substantially larger than Phas…
Phase II full R&D execution by small businesses expanding successful Phase I work in aging biology, Alzheimer's disease, and AD/ADRD interventions.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline